Correlation Between Neuropace and Danaher
Can any of the company-specific risk be diversified away by investing in both Neuropace and Danaher at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Danaher into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Danaher, you can compare the effects of market volatilities on Neuropace and Danaher and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Danaher. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Danaher.
Diversification Opportunities for Neuropace and Danaher
Excellent diversification
The 3 months correlation between Neuropace and Danaher is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Danaher in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Danaher and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Danaher. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Danaher has no effect on the direction of Neuropace i.e., Neuropace and Danaher go up and down completely randomly.
Pair Corralation between Neuropace and Danaher
Given the investment horizon of 90 days Neuropace is expected to generate 4.3 times more return on investment than Danaher. However, Neuropace is 4.3 times more volatile than Danaher. It trades about 0.22 of its potential returns per unit of risk. Danaher is currently generating about -0.22 per unit of risk. If you would invest 646.00 in Neuropace on September 13, 2024 and sell it today you would earn a total of 431.00 from holding Neuropace or generate 66.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Danaher
Performance |
Timeline |
Neuropace |
Danaher |
Neuropace and Danaher Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Danaher
The main advantage of trading using opposite Neuropace and Danaher positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Danaher can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danaher will offset losses from the drop in Danaher's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Danaher vs. Avita Medical | Danaher vs. Sight Sciences | Danaher vs. Treace Medical Concepts | Danaher vs. Neuropace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |